Effect of processing on the microbiological quality and safety of chicken carcasses at slaughterhouse

Microbiological contamination of chicken meat depends on the conditions under which the animals are reared, slaughtered and processed. The aim of this study was to determine the influence of farm origin and processing stages at slaughterhouse on the microbial safety and quality of chicken. Samples of chicken carcasses from three different farms were taken from a slaughterhouse. Mesophiles, Escherichia coli, coagulase positive Staphylococcci counts, presence of Listeria monocytogenes,Campylobacter and Salmonella were determined at five sampling points: after defeathering, after evisceration, after washing, after chilling and after cutting. Chilling reduced log numbers of mesophiles, coagulase positive Staphylococci and E. coli by 0.85, 1.52 and 2.2 log units, respectively. Salmonella was not detected after chilling. High prevalence of Campylobacter spp was observed at all the stages ranging between 84% and 100%. L. monocytogenes was not detected in chicken carcasses after defeathering. However, it was detected after evisceration and after washing and chilling. The most critical stage for L. monocytogenes contamination was the portioning operation, the prevalence in breast and legs being 88% and 84%, respectively.     

Pharmacotherapeutics and molecular docking studies of alpha-synuclein modulators as promising therapeutics for Parkinson’s disease

Parkinson’s disease (PD) is an age-related neurodegenerative ailment that affects dopamine-producing neurons in a specific area of the brain called the substantia nigra of the ventral midbrain. It is clinically characterized by movement disorder and marked with unusual synaptic protein alpha-synuclein accumulation in the brain. To date, only a few Food and Drug Administration (FDA) approved drugs are available on the market for the treatment of PD. Nonetheless, these drugs show parasympathomimetic related adverse events and remarkably higher toxicity; hence, it is important to find more efficacious molecules to treat PD. In our study, We chosen 22 natural compounds as inhibitors that potentially block the alpha-synuclein clump—the pathological hallmark of PD—and provide new avenues for its treatment. Most of these molecules exhibited good pharmacokinetic behaviors, making them decisively favorable drug candidates to cure PD. Molecular docking studies were performed to investigate the binding interactions between natural compounds and alpha-synuclein as anti-Parkinson drug targets. Among the examined compounds, curcumin and piperine emerged as promising phytochemicals with the highest binding affinity, key residual stable bindings and showed a good inhibitory features. Thus, the present study indicates that curcumin and piperine hold the potential to be developed as treatment options against PD. Experimental validations are needed for insights into their mechanism of action and potential clinical application.     

基于QFD的社区老年人慢性病管理产品服务系统设计研究

以老年慢性病患者为研究对象,以提高社区居家养老模式下的老年慢性病管理水平为研究目标,以提供社区卫生机构慢性病管理产品服务方案为实践目标。在数据收集和分析阶段,采用定性研究的方法收集用户数据,通过构建典型人物模型总结现有问题;通过分解典型场景中的用户需求,得出对应的具体服务需求和服务内容;并以KANO模型的结果为依据,划分服务需求的类型。在服务模型构建阶段,以QFD方法及相关理论为指导,构建质量屋,输出用户需求对应的服务特性重要度排序,并依照设计原则评估。构建基于不同类型用户需求的质量屋,得出慢性病管理有关的服务特性在社区场景下的重要度排序,并提出面向社区老年人的慢性病管理产品服务系统设计策略。     

Potential of the Electronic Nose for the Detection of Respiratory Diseases with and without Infection

Respiratory tract infections are common, and when affecting the lower airways and lungs, can result in significant morbidity and mortality. There is an unfilled need for simple, non-invasive tools that can be used to screen for such infections at the clinical point of care. The electronic nose (eNose) is a novel technology that detects volatile organic compounds (VOCs). Early studies have shown that certain diseases and infections can result in characteristic changes in VOC profiles in the exhaled breath. This review summarizes current knowledge on breath analysis by the electronic nose and its potential for the detection of respiratory diseases with and without infection.     

胆汁酸代谢调节炎症性肠病的作用机制及药物研发

炎症性肠病（IBD）是一种慢性复发性肠道炎症性疾病，发病率及非致死性疾病负担在全世界都有累加的趋势，其病因复杂，发病机制目前还未完全明确。胆汁酸（BAs）是胆汁的主要成份，其可通过与胆汁酸受体结合、调节肠道菌群等参与IBD的发生发展。本文着重讨论BAs代谢在IBD发病中的作用机制，以及基于BAs及其相关靶点的药物研发进展，为今后IBD的预防、治疗和预后研究奠定基础。     

Visceral Obesity and Its Shared Role in Cancer and Cardiovascular Disease: A Scoping Review of the Pathophysiology and Pharmacological Treatments

The association between obesity, cancer and cardiovascular disease (CVD) has been demonstrated in animal and epidemiological studies. However, the specific role of visceral obesity on cancer and CVD remains unclear. Visceral adipose tissue (VAT) is a complex and metabolically active tissue, that can produce different adipokines and hormones, responsible for endocrine-metabolic comorbidities. This review explores the potential mechanisms related to VAT that may also be involved in cancer and CVD. In addition, we discuss the shared pharmacological treatments which may reduce the risk of both diseases. This review highlights that chronic inflammation, molecular aspects, metabolic syndrome, secretion of hormones and adiponectin associated to VAT may have synergistic effects and should be further studied in relation to cancer and CVD. Reductions in abdominal and visceral adiposity improve insulin sensitivity, lipid profile and cytokines, which consequently reduce the risk of CVD and some cancers. Several medications have shown to reduce visceral and/or subcutaneous fat. Further research is needed to investigate the pathophysiological mechanisms by which visceral obesity may cause both cancer and CVD. The role of visceral fat in cancer and CVD is an important area to advance. Public health policies to increase public awareness about VAT’s role and ways to manage or prevent it are needed.     

Circulating Insulin-Like Growth Factor I is Involved in the Effect of High Fat Diet on Peripheral Amyloid β Clearance

Obesity is a risk factor for Alzheimer’s disease (AD), but underlying mechanisms are not clear. We analyzed peripheral clearance of amyloid β (Aβ) in overweight mice because its systemic elimination may impact brain Aβ load, a major landmark of AD pathology. We also analyzed whether circulating insulin-like growth factor I (IGF-I) intervenes in the effects of overweight as this growth factor modulates brain Aβ clearance and is increased in the serum of overweight mice. Overweight mice showed increased Aβ accumulation by the liver, the major site of elimination of systemic Aβ, but unaltered brain Aβ levels. We also found that Aβ accumulation by hepatocytes is stimulated by IGF-I, and that mice with low serum IGF-I levels show reduced liver Aβ accumulation—ameliorated by IGF-I administration, and unchanged brain Aβ levels. In the brain, IGF-I favored the association of its receptor (IGF-IR) with the Aβ precursor protein (APP), and at the same time, stimulated non-amyloidogenic processing of APP in astrocytes, as indicated by an increased sAPPα/sAPPβ ratio after IGF-I treatment. Since serum IGF-I enters into the brain in an activity-dependent manner, we analyzed in overweight mice the effect of brain activation by environmental enrichment (EE) on brain IGF-IR phosphorylation and its association to APP, as a readout of IGF-I activity. After EE, significantly reduced brain IGF-IR phosphorylation and APP/IGF-IR association were found in overweight mice as compared to lean controls. Collectively, these results indicate that a high-fat diet influences peripheral clearance of Aβ without affecting brain Aβ load. Increased serum IGF-I likely contributes to enhanced peripheral Aβ clearance in overweight mice, without affecting brain Aβ load probably because its brain entrance is reduced.     

新冠肺炎应急临床试验设计中的统计学考虑

新型冠状病毒肺炎的突然来袭，国内各地相继启动重大突发公共卫生事件一级响应。为了探索新冠肺炎的治疗，百余项临床研究陆续在国内开展。在突发公共卫生事件下，尽早找到有效的药物和治疗方案对于疾病的控制更加重要，这也对在这种应急情况下所开展临床试验的时效性提出要求，尤其是针对新冠肺炎的注册临床试验。本文从统计学角度，对应急临床试验中临床终点的选择和试验设计中的相关问题进行探讨。     

Estimating epidemic coupling between populations from the time to invasion

Identifying the mechanisms by which diseases spread among populations is important for understanding and forecasting patterns of epidemics and pandemics. Estimating transmission coupling among populations is challenging because transmission events are difficult to observe in practice, and connectivity among populations is often obscured by local disease dynamics. We consider the common situation in which an epidemic is seeded in one population and later spreads to a second population. We present a method for estimating transmission coupling between the two populations, assuming they can be modelled as susceptible–infected–removed (SIR) systems. We show that the strength of coupling between the two populations can be estimated from the time taken for the disease to invade the second population. Confidence in the estimate is low if only a single invasion event has been observed, but is substantially improved if numerous independent invasion events are observed. Our analysis of this simplest, idealized scenario represents a first step toward developing and verifying methods for estimating epidemic coupling among populations in an ever-more-connected global human population.